USANA Health Sciences, Inc. (USNA) Director Sells $1,119,139.94 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 17,107 shares of the stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $65.42, for a total value of $1,119,139.94. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

USANA Health Sciences, Inc. (NYSE:USNA) opened at $65.85 on Tuesday. USANA Health Sciences, Inc. has a fifty-two week low of $52.55 and a fifty-two week high of $71.00. The company has a market capitalization of $1,569.11, a price-to-earnings ratio of 17.30 and a beta of 1.07.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, topping the consensus estimate of $0.91 by $0.11. The business had revenue of $261.77 million for the quarter, compared to analyst estimates of $259.52 million. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The company’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.40 EPS. analysts expect that USANA Health Sciences, Inc. will post 3.7 earnings per share for the current year.

USANA Health Sciences announced that its Board of Directors has initiated a share repurchase program on Tuesday, July 25th that allows the company to buyback $64.60 million in shares. This buyback authorization allows the company to purchase up to 46% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s management believes its shares are undervalued.

WARNING: “USANA Health Sciences, Inc. (USNA) Director Sells $1,119,139.94 in Stock” was first reported by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this news story on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this news story can be read at https://www.truebluetribune.com/2017/11/14/insider-selling-usana-health-sciences-inc-usna-director-sells-1119139-94-in-stock.html.

A number of research analysts have weighed in on USNA shares. Pivotal Research raised their price objective on USANA Health Sciences from $70.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, October 25th. BidaskClub upgraded USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Thursday, October 26th.

Large investors have recently modified their holdings of the stock. BNP Paribas Arbitrage SA increased its position in shares of USANA Health Sciences by 13.1% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after purchasing an additional 245 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of USANA Health Sciences by 124.7% during the 1st quarter. Victory Capital Management Inc. now owns 2,117 shares of the company’s stock worth $122,000 after purchasing an additional 1,175 shares during the last quarter. Creative Planning increased its position in shares of USANA Health Sciences by 528.0% during the 2nd quarter. Creative Planning now owns 2,512 shares of the company’s stock worth $161,000 after purchasing an additional 2,112 shares during the last quarter. SG Americas Securities LLC acquired a new stake in shares of USANA Health Sciences during the 2nd quarter worth about $162,000. Finally, Eqis Capital Management Inc. acquired a new stake in shares of USANA Health Sciences during the 2nd quarter worth about $210,000. 44.54% of the stock is owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply